Physical protection is the only way to ensure UV rays do not burn the weakened epidermis or prematurely break down the ink pigments embedded in the dermis
Sanyal AJ, Kaplan LM, Frias JP, Brouwers B, Wu Q, Thomas MK, Harris C, Schloot NC, Du Y, Mather KJ, Haupt A, Hartman ML (2024) Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
This dual-route approach is entirely speculative but illustrates the kind of creative protocol design that intranasal delivery enables
Like the international market, GLP-1 drug pipelines from leading global pharmaceutical giants like Novo Nordisk and Eli Lilly are also among the top options in the Chinese market
The glucagon component introduces new considerations, but serious adverse events attributable specifically to glucagon receptor activation were rare in clinical trials
The FDA has identified safety concerns with compounded CJC-1295, including serious adverse events such as increased heart rate and systemic vasodilatory reactions